Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/19/2025

Tick-Borne Disease Diagnosis and Prevention

Diagnosis and Testing

  • No laboratory testing is recommended for asymptomatic individuals following a tick bite, as stated by the American College of Rheumatology (strong recommendation, moderate-quality evidence) and the Infectious Diseases Society of America 1, 2
  • Tick identification can be done by submitting the removed tick for species identification, according to the American College of Rheumatology 1
  • Neurologic, cardiac, and joint symptoms can be diagnosed with specific tests, including CSF analysis, serum IgG and IgM antibodies, and lymphocytic pleocytosis, as recommended by the European Society of Clinical Microbiology and Infectious Diseases 3
  • Antibodies are typically not detectable before the second week of illness, with the highest sensitivity for antibody detection usually occurring 2-3 weeks post-bite, as noted by the CDC and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) 4, 3
  • The following table summarizes the timing of antibody detection post-bite:
Time Post-Bite Antibody Detection
0-7 days Generally negative and insensitive
7-15 days Both IgM and IgG antibodies usually detectable
2-3 weeks Highest sensitivity for antibody detection
Months to years after infection Antibodies can remain detectable even after successful treatment
  • PCR testing of whole blood specimens may be necessary for early diagnosis, especially for rickettsial diseases, as recommended by the MMWR Recommendations and Reports guidelines and the ESCMID 5, 3
  • The CDC recommends a two-tier approach for Lyme disease testing, with the first tier being Enzyme-linked immunosorbent assay (ELISA) or immunofluorescence assay (IFA), and the second tier being Western blot confirmation if the first tier is positive 4
  • Initial laboratory testing should include complete blood count (CBC) with differential, liver function tests, and serological testing for tick-borne rickettsial diseases, with PCR testing of whole blood if symptoms are present, as recommended by the CDC 5

Prevention

  • Prophylactic antibiotics may affect testing, and single-dose doxycycline (200 mg for adults, 4.4 mg/kg up to 200 mg for children) within 72 hours of tick removal may prevent disease development, as stated by the American College of Rheumatology and the Infectious Diseases Society of America (strong recommendation, moderate-quality evidence) 1, 6
  • The degree of tick engorgement correlates with longer attachment and higher risk, with higher engorgement indicating a greater risk of transmission, as noted by the Infectious Diseases Society of America 6
  • The attachment duration of ≥36 hours significantly increases the transmission risk of tick-borne diseases, highlighting the importance of prompt tick removal, as recommended by the Infectious Diseases Society of America 6
  • Different tick-borne diseases are endemic to different regions, emphasizing the need for geographic-specific risk assessment and monitoring, according to the CDC 6
  • The Infectious Diseases Society of America recommends risk stratification based on tick species, attachment duration, geographic location, and degree of engorgement of the tick, with Ixodes ticks posing the highest risk for Lyme disease 6
  • A single dose of doxycycline has shown a 67% relative risk reduction in developing Lyme disease, with a recommended dose of 200 mg for adults and 4 mg/kg up to 200 mg for children ≥8 years, to be started within 72 hours of tick removal, as recommended by the Infectious Diseases Society of America (strong recommendation, moderate-quality evidence) 1, 6
  • Clinical suspicion of tick-borne disease should prompt appropriate antibiotic therapy while awaiting test results, as recommended by the Infectious Diseases Society of America, considering geographic risks and endemic diseases in the region 6
  • Patients should be monitored for 30 days after tick bite for development of symptoms such as erythema migrans, fever, headache, muscle/joint pain, and fatigue, as suggested by the Infectious Diseases Society of America 7, 1, 8
  • Up to 40% of patients with Rocky Mountain Spotted Fever (RMSF) do not report a history of tick bite, so absence of known tick exposure should not exclude testing when clinically indicated, according to the CDC 5

REFERENCES

8

Tick Bite Treatment Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025